Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 13, 2018
Patent Application Number
14650128
Date Filed
December 5, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the PCSK9 gene, and methods of using such RNAi agents to inhibit expression of PCSK9 and methods of treating subjects having a lipid disorder, such as a hyperlipidemia.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
